Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Mar 27, 2024; 16(3): 700-709
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.700
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.700
Figure 1 Comparison of immunotherapy efficacy in gastric cancer patients with liver metastasis and those without liver metastasis.
ORR: Objective response rate; DCR: Disease control rate; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressing disease.
- Citation: Liu K, Wu CX, Liang H, Wang T, Zhang JY, Wang XT. Analysis of the impact of immunotherapy efficacy and safety in patients with gastric cancer and liver metastasis. World J Gastrointest Surg 2024; 16(3): 700-709
- URL: https://www.wjgnet.com/1948-9366/full/v16/i3/700.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i3.700